Ustekinumab-Induced Remission of Recalcitrant Guttate Psoriasis: A Case Series

JAAD Case Reports - United States
doi 10.1016/j.jdcr.2017.06.015
Full Text
Abstract

Available in full text

Categories
Dermatology
Date
Authors
Publisher

Elsevier BV

Related search

Exacerbation of Infliximab-Induced Paradoxical Psoriasis After Ustekinumab Therapy

Journal of Dermatology
DermatologyMedicine
2017English

Risankizumab vs. Ustekinumab for Plaque Psoriasis

British Journal of Dermatology
DermatologyMedicine
2019English

Risankizumab Versus Ustekinumab for Plaque Psoriasis: A Critical Appraisal

British Journal of Dermatology
DermatologyMedicine
2019English

Psoriasis: Therapie Mit Ustekinumab Ist Langzeitig Erfolgreich

hautnah dermatologie
2013English

1038 Convergent Molecular and Histologic Profiles of Guttate and Plaque Psoriasis

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

P84: Psoriasis in Recurrent Pregnancy Loss Patients: A Case Series

American Journal of Reproductive Immunology
GynecologyReproductive MedicineImmunologyObstetricsAllergy
2019English

Ustekinumab Biotherapy and Real-Time Psoriasis Capacitance Mapping: A Pilot Study

Journal of Biomedicine and Biotechnology
2012English

Serum Levels of LL-37 and Inflammatory Cytokines in Plaque and Guttate Psoriasis

Mediators of Inflammation
ImmunologyCell Biology
2014English

New Onset or Worsening of Psoriasis Following Biologic Therapy: A Case Series

International Journal of Immunopathology and Pharmacology
AllergyImmunologyPharmacology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy